Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04175444 · ClinicalTrials.gov registry record

Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer

A clinical trial, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
50
Enrollment target

NCT04175444 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04175444 has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The goal of this study is to determine reference values of the VisuALL Field Test in pediatric population. Standard Automatic Perimetry (SAP) is the gold standard test for the evaluation of different diseases of the visual pathway like glaucoma. Its main goal is to measure the differential light sensitivity at several locations in the central field of vision. Nevertheless, the accuracy of the current devices is limited by several factors such as the inherent inconsistency of the psychophysical test, stressful examinations and frequency of testing. Several devices have been developed since the advent of the Octopus Perimeter and the Humphrey Field Analyzer (HFA) in an effort to improve the early detection of glaucoma. Several of these visual field test variants are implemented using laptops, iPads, and virtual reality headsets. These modalities bring portability but lack fixation methods, environmental control, and hardware standardization. These deficiencies may limit their wide usage. The main goal of this study is to develop an initial pediatric reference database of a novel visual field test ecosystem that takes advantage of a Head Mounted Device (HMD).

Interventions

  • DIAGNOSTIC_TEST VisuALL Field Analyzer
  • DIAGNOSTIC_TEST Humphrey Field Analyzer

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-06-15
Est. Completion 2022-12-01

What the Registry Record Tells You About NCT04175444

The ClinicalTrials.gov registry entry for NCT04175444 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which VisuALL Field Analyzer is the first listed.

NCT04175444 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04175444 about?

NCT04175444 is a clinical study titled "Establishing a Normative Database in Pediatric Population of the Head-mounted visuALL Field Analyzer". The goal of this study is to determine reference values of the VisuALL Field Test in pediatric population. Standard Automatic Perimetry (SAP) is the gold standard test for the evaluation of different diseases of the visual pathway like glaucoma. Its main goal is to measure the differential light sen...

What is the current status of trial NCT04175444?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-06-15. Estimated completion is 2022-12-01.

What interventions are being tested in trial NCT04175444?

The interventions under investigation include: VisuALL Field Analyzer (DIAGNOSTIC_TEST), Humphrey Field Analyzer (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04175444?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.